ENSC - Balance Sheet - Ensysce Biosciences, Inc.

Current Liabilities	2.21 M
Accounts Payable	1.36 M
Short-Term Debt	302 K
Other Current Liabilities	548 K
Non-Current Liabilities	10.1 K
Long-Term Debt	0
Other Non-Current Liabilities	10.1 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	3.5	1.1	3.1	12.3	0.2	1.1	1.7	2.1
Short Term Investments	0	0	0	0	0	195.3	202.9	200.1
Receivables	0.1	97.6 K	0.3	0.4	0	0	0.2	0
Inventory	0	0	(0.3)	(0.4)	0	1	0	0
Other Current Assets	18 K	1.1	1.9	3.0	0.2	0.1	87.1 K	0.2
Total Current Assets	5.3	2.3	5.3	15.7	0.3	1.2	1.9	2.3
PP&E	0	0	27.2 K	24 721.0	151	351	0	0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	195.3	202.9	200.1
Other Long Term Assets	0.3	0.4	0.6	(24 720.2)	3.78 K	351	1	0
Other Assets	0	0	0	0	0	0	1	0
Total Assets	5.6	2.7	5.9	16.4	0.4	196.5	204.8	202.4
LIABILITIES
Accounts Payable	1.4	1.9	2.9	0.3	1.7	0.5	0	0
Short Term Debt	0.3	0.9	4.3	12.8	4.3	0	0	0
Other Current Liabilities	0.5	0.5	2.2	3.4	0.9	2.1	0.4	0.2
Total Current Liabilities	2.2	3.3	9.5	16.5	7.0	2.8	0.4	0.2
Long Term Debt	0	0	0.1	4.4	0	0	0	0
Deferred Tax Income	0	0	0	0	0	(7.6)	1.76 K	0
Other Liabilities	10.1 K	26.4 K	0.3	3.7	0	7.6	0	0
Total Liabilities	2.2	3.4	9.9	24.6	7.0	10.3	7.4	7.2
EQUITY
Common Stock	136	315	642	2.46 K	1.58 K	181.2	604	673
Retained Earnings	(129 544 299.0)	(121.6)	(110.9)	(85.8)	(56.0)	2.5	2.1	31.2 K
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	604	673
Total Equity	3 379 939.0	(0.7)	(4.3)	(8.4)	(6.7)	186.2	197.4	195.3
Total Liabilities and Equity	5.6	2.7	5.9	16.4	0.4	196.5	204.8	202.4
SHARES OUTSTANDING
Common Shares Outstanding	1.7	2.3	0.2	84 K	65.7 K	6.1	6.0	6.0

Free